HARRYCAT
- 17 Nov 2014 08:25
- 406 of 440
Camden Market may be set to float, according to The Sunday Times.
The British hotspot was bought up by Israeli billionaire Teddy Sagi, who has spent more than £500m to become the market’s first single owner.
Sagi last month acquired Camden lock from investment company Brockton Capital and spent £400m to purchase Camden Stables earlier in the year.
The Israeli businessman is also thought to have appointed former gaming chief executive Charles Butler to lead his Camden property operation.
skinny
- 17 Nov 2014 08:39
- 407 of 440
My son will be interested if it does - he loves the place.
HARRYCAT
- 17 Nov 2014 08:54
- 408 of 440
I think it's a terrific place to visit. I think there are quite a few ways to get ripped off, but that always adds to the buzz!
Martini
- 09 Jan 2015 07:04
- 410 of 440
More on Trainline. I am interested in this one.
More information
HARRYCAT
- 09 Jan 2015 10:09
- 412 of 440
It is often cheaper than going direct to the operator's website. Regardless of who gets what in the way of profit / commission, as long as we (the public) get a cheaper price, seems like a no brainer to me.
dreamcatcher
- 12 Jan 2015 15:12
- 413 of 440
Biotech business and tool hire firm join Trainline on the IPO track
By Andrew Neil
January 12 2015, 11:33am
Trainline, which sells tickets online and over the phone for the main train operating companies, has announced it is planning a £500mln float on the London Stock Exchange.
Trainline, which sells tickets online and over the phone for the main train operating companies, has announced it is planning a £500mln float on the London Stock Exchange.
Tool hirer HSS Hire Group and biotech business Redx Pharma are the latest firms to roll out their IPO plans.
Last week Trainline.com, the online train ticket retailer, started the 2015 IPO ball rolling when it unveiled its London flotation.
In a statement today, Liverpool-based drug developer Redx Pharma said it plans to raise £20mln when it floats on AIM in February.
Set up in 2010, the firm focuses on developing new treatments for cancer and infectious diseases by improving existing drugs to create best-in-class treatments.
Based at the former AstraZeneca site at Alderley Park, Cheshire, it already has a portfolio of 13 patent-protected drug programmes.
Already at the pre-clinical proof of concept stage are treatments for MRSA, bone tumours, skin, brain and blood cancers.
The biotech business has secured partnerships with AstraZeneca, the NHS and French laboratory Pierre Fabre in the past 18 months.
The money raised will help develop the pipeline of oncology and infectious disease assets and launch a third therapeutic subsidiary focused on immunology.
“We believe that Redx is now at the forefront of research into small molecule tumour immunology and cancer stem cells, as well as the critical threat of antimicrobial resistant infection,” said Neil Murray, chief executive.
The listing would value the firm in the region of £60-£80mln, reports today suggested. Dealing in the shares on the junior market is expected to start next month.
Meanwhile, UK tool and equipment renter HSS Hire hopes to raise more than £100mln through floating a quarter of its shares. In a statement today, the firm said it will use the proceeds to reduce its £200mln debt.
HSS, which claims to be the second-biggest supplier of hired tool and equipment in Britain, operates from 265 locations and has about 2,900 staff. The listing could give the firm a value close to £600mln.
Martini
- 22 Jan 2015 19:48
- 415 of 440
Hmmm so much for the trainline float!
Martini
- 23 Feb 2015 19:50
- 416 of 440
DFS on offer but I can't get excited by this. Any views?
skinny
- 24 Feb 2015 07:20
- 417 of 440
Barge pole, touch, wouldn't?
My local DFS seems to have a constant near empty car park.
HARRYCAT
- 02 Oct 2015 08:39
- 425 of 440
Equiniti: Intention to Float
Equiniti has today announced its intention to carry out an initial public offering (IPO) on the London Stock Exchange by issuing an intention to float announcement.
Full details of the Global Offer will be included in the prospectus expected to be published in due course. It is expected that Admission will take place in October 2015.